In the current Canadian market landscape, investors are keeping a close watch on potential changes to U.S. tax policies that could impact dividends received from American companies, alongside rising bond yields signaling shifts in global fiscal dynamics. Amid these developments, growth companies with high insider ownership can offer a compelling investment narrative, as insider confidence often aligns with strong business fundamentals and long-term potential.
Top 10 Growth Companies With High Insider Ownership In Canada
Overview: Allied Gold Corporation, along with its subsidiaries, is engaged in the exploration and production of mineral deposits in Africa and has a market cap of CA$2.21 billion.
Operations: The company's revenue is generated from its operations at the Agbaou Mine ($201.54 million), Bonikro Mine ($224.17 million), and Sadiola Mine ($476.02 million).
Insider Ownership: 16%
Allied Gold has experienced substantial insider buying recently, indicating confidence in its growth prospects. The company reported impressive Q1 2025 results with sales of US$346.41 million and a net income turnaround to US$15.12 million from a loss last year. Despite recent shareholder dilution, Allied Gold's revenue is forecast to grow significantly faster than the Canadian market at 22.9% annually, supported by strong production guidance and a strategic stock split effective May 22, 2025.
Overview: Knight Therapeutics Inc. is engaged in acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products across Canada and Latin America with a market cap of CA$576.84 million.
Operations: The company's revenue primarily comes from its pharmaceuticals segment, which generated CA$372.78 million.
Insider Ownership: 22.8%
Knight Therapeutics demonstrates promising growth potential, with earnings expected to grow significantly at 23.3% annually, outpacing the Canadian market. The company recently became profitable, reporting a Q1 net income of CAD 2.19 million compared to a loss previously. Despite trading below its fair value and analyst price targets suggesting potential upside, Knight's revenue growth forecast of 7.4% remains modest relative to high-growth benchmarks but exceeds the broader market average in Canada.
Overview: WELL Health Technologies Corp. is a practitioner-focused digital healthcare company operating in Canada, the United States, and internationally with a market cap of CA$1.02 billion.
Operations: The company's revenue segments include SaaS and Technology Services at CA$79.59 million, Specialized-provider Staffing at CA$145.96 million, Canadian Patient Services - Primary at CA$207.89 million, WELL Health USA Patient Services - Primary WISP at CA$109.39 million, Canadian Patient Services - Specialized Myhealth at CA$135.67 million, WELL Health USA Patient Services - Primary Circle Medical at CA$85.37 million, and WELL Health USA Patient Services - Specialized CRH Medical at CA$235.22 million.
Insider Ownership: 22.5%
WELL Health Technologies is forecast to achieve profitability within three years, with earnings expected to grow significantly at 77.63% annually. Despite a Q1 net loss of CAD 46.57 million, the company is trading at 68.3% below its estimated fair value, with analysts predicting an 86.1% price increase potential. Revenue growth of 16.4% per year surpasses the Canadian market average, supported by strategic leadership changes in its cybersecurity division under Jeffrey Engle's guidance.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include TSX:AAUC TSX:GUD and TSX:WELL.
